Home page > Products > Lamzede®

Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Authorize the processing of personal data

Lamzede®

Active Ingredient: velmanase alfa

Velmase alfa treatment is indicated in patients with mild to moderate alpha-mannosidosis for the treatment of non-neurological manifestations. Enzyme replacement therapy is given as an infusion once a week.

 

For more information about therapy you can find on the corporate webs Chiesi Global Rare Diseases.